Human clinical trials for Covaxin begins at Hyderabad NIMS
The Phase-1 Human Clinical Trials for Covaxin, vaccine candidate from India for COVID-19, has started at Nizam’s Institute of Medical Sciences (NIMS)
Full Article
Human clinical trials for Covaxin begins at Hyderabad NIMS
Hindu
0 shares
1 views
You might like
Related news coverage
Phase-I human clinical trials complete, India's COVID-19 vaccine 'Covaxin' tested on 375 volunteers
DNA
Covaxin has been developed by Bharat Biotech, a pharmaceutical company based in Hyderabad.